Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)Chunmei Bai,Jianming Xu,Lin Shen,Jie Li,Zhiwei Zhou,Zhiping Li,Yihebali Chi,Xianjun Yu,Enxiao Li,Nong Xu,Tianshu Liu,Wenhui Lou,Yuxian Bai,Xianglin Yuan,Xiuwen Wang,Ying Yuan,Jia Chen,Sha Guan,Songhua Fan,Weiguo SuPANCREAS（2022）引用 0|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
